NCT07055867View on ClinicalTrials.gov

Epidemiological and Clinical Characteristics of Mpox Outbreak in Equateur, the DR Congo (Part1)

Enrolling by invitationOBSERVATIONAL
Enrollment

122

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Mpox (Monkeypox)
Trial Locations (1)

Unknown

Equateur Provincial Public Health Laboratory, Mbandaka

All Listed Sponsors
collaborator

Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo

OTHER

lead

Osaka Metropolitan University

OTHER